APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Invasive Prenatal Screening (NIPS)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-Invasive Prenatal Screening (NIPS) Industry Growth and Trends Forecast to 2032

11 April 2026103 pages

Choose your research edition.

Industry ResearchNon-Invasive Prenatal Screening (NIPS) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Invasive Prenatal Screening (NIPS) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Non-Invasive Prenatal Screening (NIPS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Invasive Prenatal Screening (NIPS) Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Non-Invasive Prenatal Screening (NIPS) Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

According to APO Research, the global Non-Invasive Prenatal Screening (NIPS) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-Invasive Prenatal Screening (NIPS) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-Invasive Prenatal Screening (NIPS) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Invasive Prenatal Screening (NIPS) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Non-Invasive Prenatal Screening (NIPS) market include Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Veritas Genetics, GGA, Cordlife and BGI Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-Invasive Prenatal Screening (NIPS) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-Invasive Prenatal Screening (NIPS) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-Invasive Prenatal Screening (NIPS) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-Invasive Prenatal Screening (NIPS).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Non-Invasive Prenatal Screening (NIPS) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-Invasive Prenatal Screening (NIPS) Market by Company

Revvity

Quest Diagnostics

MedGenome

Mayo Clinic Laboratories

SYNLAB

Veritas Genetics

GGA

Cordlife

BGI Genomics

Berry Genomics

Annaroad

Genesky

Weihansi Biomedical Technology

Non-Invasive Prenatal Screening (NIPS) Segment by Type

Screening in Uncomplicated Pregnancies

Screening in High-Risk Pregnancies

Others

Non-Invasive Prenatal Screening (NIPS) Segment by Application

Public Hospitals

Private Hospitals

Non-Invasive Prenatal Screening (NIPS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive Prenatal Screening (NIPS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive Prenatal Screening (NIPS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive Prenatal Screening (NIPS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Non-Invasive Prenatal Screening (NIPS) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Non-Invasive Prenatal Screening (NIPS) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2021-2026) Table 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2027-2032) Table 6. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2021-2026) Table 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Non-Invasive Prenatal Screening (NIPS) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Non-Invasive Prenatal Screening (NIPS) Market Size Share by Application (2021-2026) Table 24. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Non-Invasive Prenatal Screening (NIPS) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Non-Invasive Prenatal Screening (NIPS) Industry Trends Table 37. Non-Invasive Prenatal Screening (NIPS) Industry Drivers Table 38. Non-Invasive Prenatal Screening (NIPS) Industry Opportunities and Challenges Table 39. Non-Invasive Prenatal Screening (NIPS) Industry Restraints Table 40. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Company (2021-2026) Table 42. Global Non-Invasive Prenatal Screening (NIPS) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Non-Invasive Prenatal Screening (NIPS) Key Company Headquarters & Area Served Table 44. Global Non-Invasive Prenatal Screening (NIPS) Company, Product Type & Application Table 45. Global Non-Invasive Prenatal Screening (NIPS) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Non-Invasive Prenatal Screening (NIPS) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Revvity Company Information Table 49. Revvity Business Overview Table 50. Revvity Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Revvity Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 52. Revvity Recent Development Table 53. Quest Diagnostics Company Information Table 54. Quest Diagnostics Business Overview Table 55. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 57. Quest Diagnostics Recent Development Table 58. MedGenome Company Information Table 59. MedGenome Business Overview Table 60. MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. MedGenome Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 62. MedGenome Recent Development Table 63. Mayo Clinic Laboratories Company Information Table 64. Mayo Clinic Laboratories Business Overview Table 65. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 67. Mayo Clinic Laboratories Recent Development Table 68. SYNLAB Company Information Table 69. SYNLAB Business Overview Table 70. SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. SYNLAB Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 72. SYNLAB Recent Development Table 73. Veritas Genetics Company Information Table 74. Veritas Genetics Business Overview Table 75. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 77. Veritas Genetics Recent Development Table 78. GGA Company Information Table 79. GGA Business Overview Table 80. GGA Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GGA Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 82. GGA Recent Development Table 83. Cordlife Company Information Table 84. Cordlife Business Overview Table 85. Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Cordlife Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 87. Cordlife Recent Development Table 88. BGI Genomics Company Information Table 89. BGI Genomics Business Overview Table 90. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 92. BGI Genomics Recent Development Table 93. Berry Genomics Company Information Table 94. Berry Genomics Business Overview Table 95. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 97. Berry Genomics Recent Development Table 98. Annaroad Company Information Table 99. Annaroad Business Overview Table 100. Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Annaroad Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 102. Annaroad Recent Development Table 103. Genesky Company Information Table 104. Genesky Business Overview Table 105. Genesky Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Genesky Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 107. Genesky Recent Development Table 108. Weihansi Biomedical Technology Company Information Table 109. Weihansi Biomedical Technology Business Overview Table 110. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product Portfolio Table 112. Weihansi Biomedical Technology Recent Development Table 113. North America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2026) Table 116. North America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Country (2027-2032) Table 118. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2026) Table 121. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2026) Table 126. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Country (2027-2032) Table 128. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2026) Table 131. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2026) Table 136. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Non-Invasive Prenatal Screening (NIPS) Product Image Figure 3. Global Non-Invasive Prenatal Screening (NIPS) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032) & (US$ Million) Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region: 2025 VS 2032 Figure 6. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2021-2032) Figure 7. North America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Screening in Uncomplicated Pregnancies Image Figure 13. Global Screening in Uncomplicated Pregnancies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Screening in High-Risk Pregnancies Image Figure 15. Global Screening in High-Risk Pregnancies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type 2025 VS 2032 Figure 20. North America Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2021-2032) Figure 21. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2021-2032) Figure 23. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Share by Type (2021-2032) Figure 25. Public Hospitals Image Figure 26. Global Public Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Private Hospitals Image Figure 28. Global Private Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application 2025 VS 2032 Figure 31. North America Non-Invasive Prenatal Screening (NIPS) Market Size Share by Application (2021-2032) Figure 32. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Share by Application (2021-2032) Figure 34. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Non-Invasive Prenatal Screening (NIPS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 41. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 44. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 47. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Non-Invasive Prenatal Screening (NIPS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 50. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Screening in Uncomplicated Pregnancies
  • Screening in High-Risk Pregnancies
  • Others
Applications
  • Public Hospitals
  • Private Hospitals
Companies covered
  • Revvity
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • SYNLAB
  • Veritas Genetics
  • GGA
  • Cordlife
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Genesky
  • Weihansi Biomedical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2032)
  5. 1.4.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026)
  6. 1.4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032)
  8. 1.5.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032)
2 Non-Invasive Prenatal Screening (NIPS) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Screening in Uncomplicated Pregnancies
  3. 2.1.2 Screening in High-Risk Pregnancies
  4. 2.1.3 Others
  5. 2.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type
  6. 2.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Non-Invasive Prenatal Screening (NIPS) Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Regions
  10. 2.3.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Type (2021-2026)
3 Non-Invasive Prenatal Screening (NIPS) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Public Hospitals
  3. 3.1.2 Private Hospitals
  4. 3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application
  5. 3.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Non-Invasive Prenatal Screening (NIPS) Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Regions
  9. 3.3.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Non-Invasive Prenatal Screening (NIPS) Industry Trends
  2. 4.2 Non-Invasive Prenatal Screening (NIPS) Industry Drivers
  3. 4.3 Non-Invasive Prenatal Screening (NIPS) Industry Opportunities and Challenges
  4. 4.4 Non-Invasive Prenatal Screening (NIPS) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2026)
  2. 5.2 Global Non-Invasive Prenatal Screening (NIPS) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Non-Invasive Prenatal Screening (NIPS) Key Company Headquarters & Area Served
  4. 5.4 Global Non-Invasive Prenatal Screening (NIPS) Company, Product Type & Application
  5. 5.5 Global Non-Invasive Prenatal Screening (NIPS) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Non-Invasive Prenatal Screening (NIPS) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Non-Invasive Prenatal Screening (NIPS) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Revvity
  2. 6.1.1 Revvity Company Information
  3. 6.1.2 Revvity Business Overview
  4. 6.1.3 Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Revvity Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  6. 6.1.5 Revvity Recent Developments
  7. 6.2 Quest Diagnostics
  8. 6.2.1 Quest Diagnostics Company Information
  9. 6.2.2 Quest Diagnostics Business Overview
  10. 6.2.3 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  12. 6.2.5 Quest Diagnostics Recent Developments
  13. 6.3 MedGenome
  14. 6.3.1 MedGenome Company Information
  15. 6.3.2 MedGenome Business Overview
  16. 6.3.3 MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 MedGenome Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  18. 6.3.5 MedGenome Recent Developments
  19. 6.4 Mayo Clinic Laboratories
  20. 6.4.1 Mayo Clinic Laboratories Company Information
  21. 6.4.2 Mayo Clinic Laboratories Business Overview
  22. 6.4.3 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  24. 6.4.5 Mayo Clinic Laboratories Recent Developments
  25. 6.5 SYNLAB
  26. 6.5.1 SYNLAB Company Information
  27. 6.5.2 SYNLAB Business Overview
  28. 6.5.3 SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 SYNLAB Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  30. 6.5.5 SYNLAB Recent Developments
  31. 6.6 Veritas Genetics
  32. 6.6.1 Veritas Genetics Company Information
  33. 6.6.2 Veritas Genetics Business Overview
  34. 6.6.3 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  36. 6.6.5 Veritas Genetics Recent Developments
  37. 6.7 GGA
  38. 6.7.1 GGA Company Information
  39. 6.7.2 GGA Business Overview
  40. 6.7.3 GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GGA Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  42. 6.7.5 GGA Recent Developments
  43. 6.8 Cordlife
  44. 6.8.1 Cordlife Company Information
  45. 6.8.2 Cordlife Business Overview
  46. 6.8.3 Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Cordlife Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  48. 6.8.5 Cordlife Recent Developments
  49. 6.9 BGI Genomics
  50. 6.9.1 BGI Genomics Company Information
  51. 6.9.2 BGI Genomics Business Overview
  52. 6.9.3 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  54. 6.9.5 BGI Genomics Recent Developments
  55. 6.10 Berry Genomics
  56. 6.10.1 Berry Genomics Company Information
  57. 6.10.2 Berry Genomics Business Overview
  58. 6.10.3 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  60. 6.10.5 Berry Genomics Recent Developments
  61. 6.11 Annaroad
  62. 6.11.1 Annaroad Company Information
  63. 6.11.2 Annaroad Business Overview
  64. 6.11.3 Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Annaroad Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  66. 6.11.5 Annaroad Recent Developments
  67. 6.12 Genesky
  68. 6.12.1 Genesky Company Information
  69. 6.12.2 Genesky Business Overview
  70. 6.12.3 Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Genesky Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  72. 6.12.5 Genesky Recent Developments
  73. 6.13 Weihansi Biomedical Technology
  74. 6.13.1 Weihansi Biomedical Technology Company Information
  75. 6.13.2 Weihansi Biomedical Technology Business Overview
  76. 6.13.3 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product Portfolio
  78. 6.13.5 Weihansi Biomedical Technology Recent Developments
7 North America
  1. 7.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  3. 7.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  3. 8.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  3. 10.3 South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst